are recommended for venous thromboembolism (VTE) prophylaxis in acutely ill medical
patients. There are limited data on the safety of fondaparinux for VTE prophylaxis in
ischemic stroke. We examined adverse event frequency in hospitalized patients with
ischemic stroke who received VTE prophylaxis with fondaparinux versus UFH. Materials and
Methods We performed a propensity score matched analysis on a retrospective cohort of …